Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.

scientific article published on September 2003

Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.171.6.2789
P698PubMed publication ID12960299
P5875ResearchGate publication ID10579213

P50authorRene E ToesQ42494390
P2093author name stringShixuan Wang
Jerry Y Niederkorn
Martine J Jager
Zita F H M Boonman
Hao-Chuan Li
YuGuang He
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)2789-2796
P577publication date2003-09-01
P1433published inJournal of ImmunologyQ3521441
P1476titleRole of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye
P478volume171

Reverse relations

cites work (P2860)
Q42183991Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors
Q81459070CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages
Q35153266CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination
Q35848101Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy.
Q37905546Cornea: Window to Ocular Immunology
Q34325061Corneal transplantation and immune privilege
Q40230085Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma
Q40086525Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.
Q36024156Gamma c cytokines condition the progressive differentiation of CD4+ T cells
Q39835934Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
Q41780299Good news-bad news: the Yin and Yang of immune privilege in the eye.
Q35269684IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.
Q37521988Immune cell-mediated liver injury
Q37535138Immune escape mechanisms of intraocular tumors
Q36100283Immunology of intraocular tumors
Q36285926Influence of CD8+ T regulatory cells on intraocular tumor development
Q37724789Influence of immune privilege on ocular tumor development
Q30375264Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection
Q42200330Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?
Q36426813See no evil, hear no evil, do no evil: the lessons of immune privilege
Q34646470Splenectomy promotes indirect elimination of intraocular tumors by CD8+ T cells that is associated with IFNγ- and Fas/FasL-dependent activation of intratumoral macrophages
Q44786845TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus
Q57078133TRAIL-induced cell death cooperates with IFN-γ activation in the graft-versus-tumor effect against colon tumors
Q28073631The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
Q24672443p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines

Search more.